| abstract |
In many of its embodiments, the present invention relates to a novel class of pyrazolo [1,5-a] pyrimidine compounds as inhibitors of cyclin dependent kinases, methods for the preparation of such compounds, one or more such compounds. Pharmaceutical compositions containing, methods of preparing pharmaceutical formulations containing one or more such compounds, and using such compounds or pharmaceutical compositions, one or more associated with CDK Methods of treating, preventing, preventing or alleviating a disease are provided. |